YSYoko Schreiber

Yoko Schreiber

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yoko Schreiber has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities

    by Lena Faust, Yoko Schreiber, Natalie Bocking

    Background: Bacille Calmette-Guérin (BCG) vaccination against tuberculosis (TB) is widespread in high-TB-burden countries, however, BCG vaccination policies in low-burden countries vary. Considering the uncertainties surrounding BCG efficacy and the lower likelihood of TB exposure in low-incidence countries, most have discontinued mass vaccination, choosing instead a targeted vaccination strategy among high-risk groups. Given the increased risk of TB infection in Canadian Indigenous communities compared to the general Canadian population, these communities are a pertinent example of high-incidence groups in an otherwise low-burden country, warranting particular consideration regarding BCG vaccination strategy. This systematic review aims to synthesise and critically appraise the literature on BCG vaccination strategies in high-risk groups in low-incidence settings to provide policy considerations relevant to the Canadian Indigenous context.Methods:A literature search of the Medline and Embase databases was conducted, returning studies pertaining to BCG vaccine efficacy, TB incidence under specific vaccination policies, BCG-associated adverse events, and vaccination policy guidelines in low-burden countries. Study screening was tracked using the Covidence systematic review software (Veritas Health Innovation, Melbourne, Australia), and data pertaining to the above points of interest were extracted.Results: The final review included 49 studies, spanning 15 countries. Although almost all of these countries had implemented a form of mass or routine vaccination previously, 11 have since moved to targeted vaccination of selected risk groups, in most cases due to the low risk of infection among the general population and thus the high number of vaccinations needed to prevent one case in the context of low-incidence settings. Regarding identifying risk groups for targeted screening, community-based (rather than individual risk-factor-based) vaccination has been found to be beneficial in high-incidence communities within low-incidence countries, suggesting this approach may be beneficial in the Canadian Indigenous setting.Conclusions: Community-based vaccination of high-incidence communities may be beneficial in the Canadian Indigenous context, however, where BCG vaccination is implemented, delivery strategies and potential barriers to achieving adequate coverage in this setting should be considered. Where an existing vaccination program is discontinued, it is crucial that an effective TB surveillance system is in place, and that case-finding, screening, and diagnostic efforts are strengthened in order to ensure adequate TB control. This is particularly relevant in Canadian Indigenous and other remote or under-served communities, where barriers to surveillance, screening, and diagnosis persist.


  • Open Access

    Prevalence of chronic kidney disease and cardiovascular comorbidities in adults in First Nations communities in northwest Ontario: a retrospective observational study

    by Len Kelly, Cai-Lei Matsumoto, Yoko Schreiber, Janet Gordon, Hannah Willms, Christopher Olivier, Sharen Madden, Josh Hopko, Sheldon W. Tobe

    Background: The prevalence of adult chronic kidney disease and cardiovascular comorbidities in Canadian Indigenous communities is largely unknown. We conducted a study to document the prevalence of chronic kidney disease and concurrent diabetes mellitus, hypertension and dyslipidemia in a First Nations population in northwest Ontario. Methods: In this observational study, we used retrospective data collected from regional electronic medical records of 16 170 adults (age ≥ 18 yr) from 26 First Nations communities in northwest Ontario from May 2014 to May 2017. Demographic and laboratory data included age, gender, prescribed medications, estimated glomerular filtration rate, urine albumin:creatinine ratio, low-density lipoprotein cholesterol (LDL-C) level and glycated hemoglobin (HbA1c) concentration. We identified patients with diabetes by an HbA1c concentration of 6.5% or higher, or the use of a diabetic medication, those with dyslipidemia by an elevated LDL-C level (≥ 2.0 mmol/L) or use of lipid-lowering medication, and those with hypertension by use of antihypertensive medication. Results: Of the 16 170 adults residing in the communities, 5224 unique patients (32.3%) had renal testing (albumin:creatinine ratio and/or estimated glomerular filtration rate). The age-adjusted prevalence of chronic kidney disease was 14.5%, and the prevalence of stage 3–5 chronic kidney disease (estimated glomerular filtration rate < 60 mL/min) was 7.0%. Most patients with chronic kidney disease (1487 [80.0%]) had at least 1 cardiovascular comorbidity. A total of 1332 patients (71.6%) had diabetes, 1313 (70.6%) had dyslipidemia, and 1098 (59.1%) had hypertension; all 3 comorbidities were present in 716 patients (38.5%). Interpretation: We document a high prevalence of advanced chronic kidney disease in this First Nations population, 7.0%, double the rate in the general population. High rates of cardiovascular comorbidities were also common in these patients with chronic kidney disease, which places them at increased risk for cardiovascular disease.


  • Open Access

    Recommendations for the screening of paediatric latent tuberculosis infection in indigenous communities: a systematic review of screening strategies among high-risk groups in low-incidence countries

    by Lena Faust, Anne McCarthy, Yoko Schreiber

    Tuberculosis (TB) continues to be a global public health concern. Due to the presence of multiple risk factors such as poor housing conditions and food insecurity in Canadian Indigenous communities, this population is at particularly high risk of TB infection. Given the challenges of screening for latent TB infection (LTBI) in remote communities, a synthesis of the existing literature regarding current screening strategies among high-risk groups in low-incidence countries is warranted, in order to provide an evidence base for the optimization of paediatric LTBI screening practices in the Canadian Indigenous context. A literature search of the Embase and Medline databases was conducted, and studies pertaining the evaluation of screening strategies or screening tools for LTBI in paediatric high-risk groups in low-incidence countries were included. Studies focusing on LTBI screening in Indigenous communities were also included, regardless of whether they focused on a paediatric population. Their results were summarized and discussed in the context of their relevance to screening strategies suitable to the Canadian Indigenous setting. Grey literature sources such as government reports or policy briefs were also consulted. The initial literature search returned 327 studies, with 266 being excluded after abstract screening, and 36 studies being included in the final review (original research studies: n = 25, review papers or policy recommendations: n = 11). In the examined studies, case identification and cost-effectiveness of universal screening were low in low-incidence countries. Therefore, studies generally recommended targeted screening of high-risk groups in low-incidence countries, however, there remains a lack of consensus regarding cut-offs for the incidence-based screening of high-risk communities, as well as regarding the utility and prioritization of individual risk-factor-based screening of high-risk groups. The utility of the TST compared to IGRAs for LTBI detection in the pediatric population also remains contested. Relevant strategies for targeted screening in the Canadian Indigenous context include community-level incidence-based screening (screening based on geographic location within high-incidence communities), as well as individual risk-factor-based screening, taking into account pertinent risk factors in Indigenous settings, such as poor housing conditions, malnutrition, contact with an active case, or the presence of relevant co-morbidities, such as renal disease.


  • Push and Pull: Migration Patterns and Links to Harm Reduction Services Among People Who Use Drugs

    by Yoko S. Schreiber, Dolly M. Lin, Katherine A. Muldoon, W. Beckerleg, Zack Marshall, Lisa Lazarus, Ashley White, Tim Ramsay, Mark Tyndall

    Objectives: The role of migration among people who use drugs (PWUD) remains a complex topic that is often shaped by risk but also has the potential for protective health outcomes. This study examines migration trends and the effect of migration on the use of social support services for PWUD in Ottawa-Gatineau region. Methods: Respondent-driven sampling was used to recruit participants residing in Ottawa-Gatineau who were ≥18 years and used drugs in the preceding 6 months. Migration was defined as a permanent change in location after ≥3 months. Push factors (reasons for leaving previous residence) and pull factors that brought them to Ottawa were explored. Bivariable and multivariable logistic regressions were conducted using odds ratio (OR), adjusted odds ratio (AOR), and 95% confidence interval (CI), respectively, to investigate the effect of migration on shelter use and accessing harm reduction services. Results: Of 398, 358 (89.95%) migrated in their lifetime and 71 (17.83%) within the last 12 months. Our sample was 79.40% male and 22.86% identified as First Nations, Inuit, or Métis. Migratory push factors included getting away from drugs or harmful friends and pull factors included returning home for family. Recent migrants had higher odds of living in a shelter (AOR: 2.51, 95% CI: 1.37–4.61) and lower odds (AOR: 0.40, 95% CI: 0.19–0.82) of accessing harm reduction services. Conclusion: PWUD are a highly mobile group and despite being motivated to migrate to reconnect with family or social networks, a high prevalence of shelter use and low uptake of harm reduction services exists. Objectifs: Le rôle de la migration chez les personnes qui consomment des drogues (PWUD) demeure un sujet complexe qui est souvent façonné par le risque, mais qui a aussi un potentiel de protection pour la santé. Cette étude examine les tendances migratoires et l’effet de la migration sur l’utilisation des services de soutien social pour les PWUD dans la région d’Ottawa-Gatineau. Méthodes: L’échantillonnage dirigé par les répondants a été utilisé pour recruter des participants résidant à Ottawa-Gatineau âgés de 18 ans ou plus et ayant consommé de la drogue au cours des six mois précédents. La migration a été définie comme un changement permanent d’emplacement après ≥3 mois. Les facteurs d’incitation (raisons de quitter la résidence antérieure) et les facteurs d’attraction qui les ont amenés à Ottawa ont été explorés. Des régressions logistiques bi-variables et multi-variées ont été menées en utilisant les rapports de cotes (odds ratios-OR), les OR ajustés et les intervalles de confiance à 95% (IC) respectivement, pour étudier l’effet de la migration sur l’utilisation des abris et l’accès aux services de réduction des risques. Résultats: Sur 398, 358 (89,95%) ont migré au cours de leur vie et 71 (17,83%) au cours des 12 derniers mois. Notre échantillon comprenait 79,40% d’hommes et 22,86% de membres des Premières Nations, d’Inuits ou de Métis. Les facteurs d’incitation migratoires incluaient s’éloigner des drogues ou des amis nuisibles et des facteurs d’attraction incluaient rentrer à la maison pour la famille. Les migrants récents avaient des chances plus élevées de vivre dans un refuge (AOR: 2,51, IC à 95%: 1,37–4,61) et des probabilités plus faibles (AOR: 0,40, IC à 95%: 0,19–0,82) d’accéder aux services de réduction des risques. Conclusion: Les PWUD constituent un groupe très mobile et, bien qu’ils soient motivés à migrer pour se reconnecter avec les réseaux familiaux ou sociaux, il existe une forte prévalence ou utilisation de refuges et une faible utilisation des services de réduction des risques.


  • Open Access

    Acute post-streptococcal glomerulonephritis in northwestern Ontario: A six-year retrospective study

    by Kassandra Loewen, Len Kelly, Chris Olivier, Mike Kirlew, Sheldon Tobe, Raphael Saginur, Yoko Schreiber

    BACKGROUND: Recent reports have described a high incidence of acute rheumatic fever in northwestern Ontario. However, the full burden of Group A streptococcal infection and its complications, including acute post-streptococcal glomerulonephritis (APSGN), in the region is not well understood. OBJECTIVE: To document the pediatric and adult incidence of APSGN in a predominantly First Nations population in northwestern Ontario. METHODS: The present study was a retrospective case series conducted over a six-year period in a population of 29,000 in northwestern Ontario. Adults and children meeting selection criteria for possible, probable, or confirmed APSGN within the study period were included. Outcome measures included patient demographics, comorbidities, investigations, clinical course, and status of renal function at last follow-up. RESULTS: The authors identified 10 pediatric and five adult cases of APSGN. The incidence rate of APSGN for children <15 years of age was 20.8 cases per 100,000 person-years and, for adults, was 4.0 cases per 100,000 person-years. These rates are comparable with those observed in developing countries and more than triple the expected rate in the rest of Canada. CONCLUSION: The incidence rate of APSGN in northwestern Ontario exceeds the norm for a developed country. Inadequate, overcrowded housing and limited access to clean water experienced by many remote First Nations communities may drive the high burden of Group A streptococcal infection and its sequelae in this region.


  • Management of infectious diseases in remote northwestern Ontario with telemedicine videoconference consultations

    by Jai Mashru, Michael Kirlew, Raphael Saginur, Yoko S Schreiber

    Northwestern Ontario in Canada provides a unique clinical challenge for providing optimal medical care. It is a large geographic area (385,000 km2) and is home to 32 remote First Nations communities, most without road access. These communities suffer a heavy burden of infectious disease and specialist consultations are difficult to obtain. The Division of Infectious Diseases at the Ottawa Hospital and the Sioux Lookout Meno Ya Win Health Centre established a telemedicine-based infectious disease consultation service in July 2014. We describe the implementation of this service, types of cases seen and patient satisfaction, as well as some of the challenges encountered. Information on visits was prospectively collected through an administrative database, and patient satisfaction surveys were administered after each initial consultation. During our first year of operation, 191 teleconsultations occurred: 76 initial consultations, 82 follow-up appointments and 33 case conferences. The scope of cases has been broad, mostly involving musculoskeletal infections (26%), followed by skin and soft tissue infections (23%). HCV, acute rheumatic fever, and respiratory infections (including pulmonary tuberculosis) were other diagnoses. Patient satisfaction has been very high and 28 telemedicine patient visits have occurred in their remote home communities, minimizing travel. The infectious disease consulting service and local clinicians have succeeded in addressing needs for care in infectious diseases in northwestern Ontario, where important gaps in service to First Nations' communities continue to exist. Regular scheduled available access to an infectious disease specialist is a well-received advancement of care in this remote region of Canada.


  • Open Access

    Fever in our First Nations

    by Janet Gordon, Mike Kirlew, Raphael Saginur, Natalie Bocking, Len Kelly, Christine Kennedy, Terri Farrell, Yoko Schreiber

    In a CMAJ practice article, Bagnall and colleagues describe acute rheumatic fever in a member of Canada’s immigrant population.[1][1] The same article correctly identifies Canada’s First Nations as a population at risk for this disease. Social determinants of health are contributory: poverty,


    • 1 January 2014
      • Vol. 19  (3) , 99-102

    Invasive CA-MRSA in northwestern Ontario: a 2-year prospective study.

    by Mike Kirlew, Sara Rea, Annette Schroeter, Donna Makahnouk, Marsha Hamilton, Nicole Brunton, Jill Muileboom, Yoko Schreiber, Raphael Saginur, Len Kelly

    Northwestern Ontario has a documented high rate of skin and soft-tissue infections due to community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Recently, invasive illness from this common pathogen has become a serious clinical problem in the region. We sought to better understand this trend of invasive CA-MRSA. We prospectively studied cases of positive CA-MRSA bacteremia in 2012 and 2013. We examined genetic typing, comorbidities and outcomes. Twenty-three cases of CA-MRSA bacteremia were treated during the 2-year study period. Intravenous drug use accounted for only 17% of cases. One death and 2 cases of endocarditis occurred. High rates of CA-MRSA in skin and soft-tissue infections, combined with poor living conditions and poor access to potable water, may account for most of these cases of CA-MRSA bacteremia. Social determinants of health are relevant when common resistant bacterial isolates become associated with life-threatening illness.


    • 1 June 2013
      • Vol. 59  (6) , 644-6

    Infective endocarditis in a new immigrant.

    by Brodie Ramin, Jana Malhotra, Yoko Schreiber, Paul Macpherson

  • Open Access

    The Use of Intravenous Antibiotics at the Onset of Neutropenia in Patients Receiving Outpatient-Based Hematopoietic Stem Cell Transplants

    by Aziz Hamadah, Yoko Schreiber, Baldwin Toye, Sheryl McDiarmid, Lothar Huebsch, Christopher Bredeson, Jason Tay

    Empirical antibiotics at the onset of febrile neutropenia are one of several strategies for management of bacterial infections in patients undergoing Hematopoietic Stem Cell Transplant (HSCT) (empiric strategy). Our HSCT program aims to perform HSCT in an outpatient setting, where an empiric antibiotic strategy was employed. HSCT recipients began receiving intravenous antibiotics at the onset of neutropenia in the absence of fever as part of our institutional policy from 01 Jan 2009; intravenous Prophylactic strategy. A prospective study was conducted to compare two consecutive cohorts [Year 2008 (Empiric strategy) vs. Year 2009 (Prophylactic strategy)] of patients receiving HSCT. There were 238 HSCTs performed between 01 Jan 2008 and 31 Dec 2009 with 127 and 111 in the earlier and later cohorts respectively. Infection-related mortality pre- engraftment was similar with a prophylactic compared to an empiric strategy (3.6% vs. 7.1%; p = 0.24), but reduced among recipients of autologous HSCT (0% vs. 6.8%; p = 0.03). Microbiologically documented, blood stream infections and clinically documented infections pre-engraftment were reduced in those receiving a prophylactic compared to an empiric strategy, (11.7% vs. 28.3%; p = 0.001), (9.9% vs. 24.4%; p = 0.003) and (18.2% vs. 33.9% p = 0.007) respectively. The prophylactic use of intravenous once-daily ceftriaxone in patients receiving outpatient based HSCT is safe and may be particularly effective in patients receiving autologous HSCT. Further studies are warranted to study the impact of this Prophylactic strategy in an outpatient based HSCT program.